Trademark: 88086496
Word
GEMCITABINE IN 0.9% SODIUM CHLORIDE INJECTION 1,200 MG PER 120 ML (10 MG/ML)
Status Date
Tuesday, October 6, 2020
Registration Number
6169996
Registration Date
Tuesday, October 6, 2020
Filing Date
Tuesday, August 21, 2018
Published for Opposition
Tuesday, January 29, 2019
5 medicinal and pharmaceutical preparations packed in ready to use infusion bags for chemotherapy, reduction of tension and anxiety, improvement of heart function, correction of hemodynamic imbalances present in the shock syndrome, blood pressure control in certain acute hypotensive states and for intravenous induction of general anesthesia or before administration of other anesthetic, all of the foregoing comprising gemcitabine; medicinal and pharmaceutical preparations packed in ready to use infusion bags for treatment of cancer, pain, diseases related to central nervous system, epilepsy, ventricular tachycardia or ventricular fibrillation, irregular heartbeat, angina, blood pressure and gynecological disorders, all of the foregoing comprising gemcitabine
10 medical apparatus, namely, infusion devices for administering drugs in the nature of ready-to-use infusion bags containing medicinal and pharmaceutical preparations of gemcitabine
The color(s) brown, white and black is/are claimed as a feature of the mark.
GEMCITABINE IN 0.9% SODIUM CHLORIDE INJECTION 1,200 MG PER 120 ML (10 MG/ML)
The mark consists of a brown outline of a rectangle surrounding the word "GEMCITABINE" in black lettering above the words "in 0.9% sodium chloride injection" along with a brown arched curve filling in the lower left hand corner, all of the foregoing above a smaller rectangle filled in brown, with the words "1,200 mg per 120 mL (10 mg/mL)" in white letters. The color white in the rectangle with the arched curve represents background only and is not claimed as a feature of the mark.
GEMCITABINE IN 0. NINE PERCENT SODIUM CHLORIDE INJECTION ONE, THOUSAND TWO HUNDRED MG PER ONE HUNDRED ML (TEN MG/ML)
Oct 6, 2020
Registered-Principal Register
Sep 3, 2020
Notice Of Acceptance Of Statement Of Use E-Mailed
Sep 2, 2020
Allowed Principal Register - Sou Accepted
Aug 13, 2020
Statement Of Use Processing Complete
Aug 4, 2020
Use Amendment Filed
Aug 13, 2020
Case Assigned To Intent To Use Paralegal
Aug 4, 2020
Teas Statement Of Use Received
Mar 20, 2020
Notice Of Approval Of Extension Request E-Mailed
Mar 18, 2020
Extension 2 Granted
Mar 18, 2020
Extension 2 Filed
Mar 18, 2020
Teas Extension Received
Sep 21, 2019
Notice Of Approval Of Extension Request E-Mailed
Sep 19, 2019
Extension 1 Granted
Sep 19, 2019
Extension 1 Filed
Sep 19, 2019
Teas Extension Received
Mar 26, 2019
Noa E-Mailed - Sou Required From Applicant
Jan 29, 2019
Official Gazette Publication Confirmation E-Mailed
Jan 29, 2019
Published For Opposition
Jan 9, 2019
Notification Of Notice Of Publication E-Mailed
Dec 21, 2018
Assigned To Lie
Nov 29, 2018
Approved For Pub - Principal Register
Nov 29, 2018
Examiner's Amendment Entered
Nov 29, 2018
Notification Of Examiners Amendment E-Mailed
Nov 29, 2018
Examiners Amendment E-Mailed
Nov 29, 2018
Examiners Amendment -Written
Nov 27, 2018
Assigned To Examiner
Aug 30, 2018
Notice Of Design Search Code E-Mailed
Aug 29, 2018
New Application Office Supplied Data Entered In Tram
Aug 24, 2018
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
